Lv51
820 积分 2022-12-30 加入
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
21天前
已完结
A novel humanized anti-HER2 antibody conjugated with MMAE exerts potent anti-tumor activity
27天前
已完结
Intravesical bacillus calmette-gueÈrin for the treatment of superficial bladder cancer in renal transplant patients
2个月前
已完结
Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life‐Chemotherapy‐Induced Peripheral Neuropathy Questionnaire (EORTC QLQ‐CIPN20) and the Functional Assessment of Cancer‐Gynecologic Oncology Group‐Neurotoxicity subscale (FACT/GOG‐Ntx)
2个月前
已完结
Chemotherapy-induced peripheral neuropathy—patient-reported outcomes compared with NCI-CTCAE grade
2个月前
已完结
Mechanisms and treatment of cancer therapy-induced peripheral and central neurotoxicity
2个月前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
3个月前
已完结
Radical cystectomy compared to intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer – is there a long-term survival difference? A Swedish nationwide analysis
3个月前
已完结
Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metastatic disease
3个月前
已完结
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
3个月前
已完结
皖公网安备34019202002308
